Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -0.27%22.04B | -4.48%13.79B | -5.65%5.89B | 0.15%30.62B | 1.05%22.1B | 0.08%14.43B | 1.26%6.25B | 6.42%30.57B | 5.87%21.87B | 5.52%14.42B |
| Refunds of taxes and levies | -11.74%50.56M | -14.49%31.17M | -15.50%8.99M | -26.10%58.43M | 8.70%57.28M | 40.26%36.46M | 31.10%10.64M | -16.16%79.06M | -22.67%52.7M | -45.24%25.99M |
| Cash received relating to other operating activities | 44.04%721.97M | 17.88%436.85M | -23.27%241.24M | 45.07%538.6M | -1.03%501.22M | 13.29%370.6M | 58.36%314.41M | 1.31%371.28M | 14.67%506.43M | 33.86%327.12M |
| Cash inflows from operating activities | 0.68%22.81B | -3.95%14.25B | -6.51%6.14B | 0.62%31.21B | 1.02%22.66B | 0.44%14.84B | 3.07%6.57B | 6.29%31.02B | 5.96%22.43B | 5.84%14.77B |
| Goods services cash paid | -0.57%13.21B | -8.07%8.29B | -5.48%4.18B | 2.48%17.52B | -0.72%13.29B | 0.27%9.02B | 2.80%4.42B | -3.57%17.1B | -0.80%13.38B | -1.49%8.99B |
| Staff behalf paid | -2.26%2.25B | -3.16%1.55B | -2.96%767.64M | 13.90%2.91B | 9.60%2.3B | 18.47%1.6B | 15.97%791.02M | -5.18%2.55B | -4.19%2.1B | -4.64%1.35B |
| All taxes paid | 14.18%2.92B | 11.07%1.97B | 6.78%891.28M | -6.28%3.3B | 4.68%2.55B | 7.81%1.77B | 17.51%834.67M | 11.30%3.52B | 12.02%2.44B | 2.18%1.64B |
| Cash paid relating to other operating activities | 6.53%1.21B | 14.37%825.64M | -1.32%410.19M | -6.71%1.5B | 13.02%1.13B | 9.15%721.89M | 19.32%415.68M | 56.76%1.61B | 26.13%1B | 22.62%661.38M |
| Cash outflows from operating activities | 1.60%19.59B | -3.65%12.63B | -3.32%6.25B | 1.81%25.24B | 1.85%19.28B | 3.66%13.11B | 6.96%6.47B | 0.68%24.79B | 1.45%18.93B | -0.35%12.65B |
| Net cash flows from operating activities | -4.56%3.23B | -6.17%1.62B | -199.22%-106.16M | -4.14%5.98B | -3.46%3.38B | -18.64%1.73B | -67.77%106.99M | 36.51%6.24B | 39.52%3.5B | 67.89%2.13B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -50.79%710M | -75.05%360M | -87.69%100M | -46.89%1.72B | -43.18%1.44B | -35.34%1.44B | -34.04%812.08M | -19.94%3.24B | -33.85%2.54B | -27.87%2.23B |
| Cash received from returns on investments | -84.46%3.82M | -86.42%3.27M | -92.34%1.71M | 101.71%48.92M | -35.50%24.58M | -34.68%24.1M | 203.45%22.32M | -25.27%24.25M | 67.62%38.11M | 84.13%36.89M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 3,535.64%432M | 4,456.76%430.97M | 27,605.40%182.75M | 98.94%439M | -41.84%11.88M | -39.42%9.46M | 382.03%659.63K | 509.90%220.67M | -19.27%20.43M | 19.40%15.61M |
| Cash received relating to other investing activities | 395.39%211.04M | -31.12%25.9M | -86.76%23.8M | -83.88%43.6M | -76.56%42.6M | -74.11%37.6M | -5.42%179.7M | 142.23%270.42M | 10.33%181.74M | 10.26%145.24M |
| Cash inflows from investing activities | -10.83%1.36B | -45.82%820.14M | -69.62%308.26M | -40.02%2.25B | -45.25%1.52B | -37.67%1.51B | -28.97%1.01B | -11.16%3.75B | -31.39%2.78B | -25.45%2.43B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -7.68%1.82B | -14.28%1.24B | 12.66%641.52M | -6.50%4.53B | -16.49%1.98B | -20.59%1.44B | -49.46%569.41M | -37.16%4.85B | -54.63%2.37B | -50.17%1.82B |
| Cash paid to acquire investments | -30.92%810.45M | -70.75%330M | -72.19%130M | -65.78%1.11B | -53.63%1.17B | -48.72%1.13B | -61.04%467.5M | -25.63%3.23B | -33.59%2.53B | -10.55%2.2B |
| Net cash paid to acquire subsidiaries and other business units | 5,076.95%5.68B | 1,009.38%1.22B | 60,408.00%1.21B | -95.15%101.79M | -82.12%109.73M | -81.59%109.73M | --2M | 3,065.66%2.1B | 1,293.87%613.72M | 2,288.23%595.88M |
| Cash paid relating to other investing activities | ---- | 1,683.41%178.34M | -27.15%178.34M | 622.87%180.72M | -72.16%10M | -71.94%10M | 9.57%244.81M | -94.78%25M | -94.49%35.91M | -85.43%35.63M |
| Cash outflows from investing activities | 154.33%8.32B | 10.08%2.96B | 68.26%2.16B | -41.97%5.92B | -41.05%3.27B | -42.10%2.69B | -49.66%1.28B | -19.04%10.21B | -42.95%5.55B | -27.10%4.65B |
| Net cash flows from investing activities | -298.10%-6.96B | -81.88%-2.14B | -588.50%-1.85B | 43.10%-3.67B | 36.84%-1.75B | 46.95%-1.18B | 76.02%-268.96M | 23.02%-6.45B | 51.21%-2.77B | 28.83%-2.22B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | 101.81%446.32M | 39.50%168.32M | ---- | ---- | -59.49%221.16M | -73.90%120.66M | -85.14%20.66M |
| Cash from bonds issue | ---- | ---- | ---- | 37.22%1.1B | ---- | ---- | ---- | -11.01%798.99M | ---- | ---- |
| Cash from borrowing | 166.72%10.56B | 71.19%3.27B | 52.82%1.9B | 7.27%5.34B | 17.66%3.96B | 2.17%1.91B | -25.18%1.25B | -9.27%4.98B | -26.48%3.36B | -31.80%1.87B |
| Cash received relating to other financing activities | 352.55%568.76M | 176.78%343.31M | 162.14%309.33M | 22.00%136.42M | 63.79%125.68M | 863.58%124.04M | 258.32%118M | 458.42%111.82M | 1,639.86%76.73M | 191.89%12.87M |
| Cash inflows from financing activities | 161.66%11.13B | 77.63%3.61B | 62.28%2.21B | 14.88%7.02B | 19.40%4.25B | 6.89%2.03B | -20.28%1.36B | -12.09%6.11B | -29.37%3.56B | -34.03%1.9B |
| Borrowing repayment | 39.64%5.23B | 36.37%1.99B | 26.28%496.47M | 23.75%5.4B | 17.69%3.74B | -44.20%1.46B | -7.15%393.14M | 108.44%4.36B | 195.64%3.18B | 220.96%2.62B |
| Dividend interest payment | -9.64%1.87B | -8.70%1.3B | 119.66%392.14M | 18.73%2.61B | 12.85%2.07B | 29.38%1.43B | 45.97%178.52M | -21.97%2.2B | -27.86%1.84B | -35.37%1.1B |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | 85.97%805.06M | ---- | ---- | ---- | 61.37%432.89M | ---- | ---- |
| Cash payments relating to other financing activities | -10.45%246.89M | -2.09%219.8M | -8.42%104.61M | -3.42%488.48M | -31.76%275.69M | -2.63%224.5M | 41.02%114.22M | 85.35%505.77M | 131.29%404M | 77.18%230.57M |
| Cash outflows from financing activities | 20.60%7.35B | 12.94%3.52B | 44.81%993.22M | 20.25%8.49B | 12.37%6.1B | -21.24%3.12B | 9.44%685.89M | 36.37%7.06B | 42.78%5.42B | 49.00%3.96B |
| Net cash flows from financing activities | 304.82%3.77B | 108.39%90.95M | 79.96%1.22B | -54.69%-1.47B | 1.06%-1.84B | 47.27%-1.08B | -37.46%678.11M | -153.72%-951.75M | -249.91%-1.86B | -1,005.46%-2.05B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -7.17%-82.78M | -128.68%-33.37M | -445.93%-26.84M | 120.97%15.89M | -178.40%-77.25M | -119.20%-14.59M | 82.28%-4.92M | -169.32%-75.81M | -36.36%98.53M | -6.36%76.01M |
| Net increase in cash and cash equivalents | 86.25%-39.41M | 15.36%-462.21M | -249.53%-764.46M | 168.14%848.92M | 72.15%-286.59M | 73.66%-546.07M | 91.62%511.23M | 35.59%-1.25B | 41.67%-1.03B | -34.05%-2.07B |
| Add:Begin period cash and cash equivalents | 15.81%6.22B | 15.81%6.22B | 15.81%6.22B | -18.83%5.37B | -18.83%5.37B | -18.83%5.37B | -18.83%5.37B | -22.62%6.62B | -22.62%6.62B | -22.62%6.62B |
| End period cash equivalent | 21.56%6.18B | 19.34%5.76B | -7.26%5.45B | 15.81%6.22B | -9.01%5.08B | 6.19%4.82B | -14.55%5.88B | -18.83%5.37B | -17.67%5.59B | -35.14%4.54B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.